EE200100134A - Kiiresti vabastav tablett - Google Patents

Kiiresti vabastav tablett

Info

Publication number
EE200100134A
EE200100134A EEP200100134A EEP200100134A EE200100134A EE 200100134 A EE200100134 A EE 200100134A EE P200100134 A EEP200100134 A EE P200100134A EE P200100134 A EEP200100134 A EE P200100134A EE 200100134 A EE200100134 A EE 200100134A
Authority
EE
Estonia
Prior art keywords
quick release
release tablet
tablet
quick
release
Prior art date
Application number
EEP200100134A
Other languages
English (en)
Inventor
Forsman Sigbrit
Karlsson Christer
Karlsson Magnus
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of EE200100134A publication Critical patent/EE200100134A/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EEP200100134A 1998-09-03 1999-08-27 Kiiresti vabastav tablett EE200100134A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9802973A SE9802973D0 (sv) 1998-09-03 1998-09-03 Immediate release tablet
PCT/SE1999/001471 WO2000013671A1 (en) 1998-09-03 1999-08-27 Immediate release tablet

Publications (1)

Publication Number Publication Date
EE200100134A true EE200100134A (et) 2002-06-17

Family

ID=20412467

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200100134A EE200100134A (et) 1998-09-03 1999-08-27 Kiiresti vabastav tablett

Country Status (32)

Country Link
US (3) US6521253B1 (et)
EP (2) EP1527787A1 (et)
JP (2) JP4026678B2 (et)
KR (2) KR100696350B1 (et)
CN (3) CN1158070C (et)
AR (1) AR029313A1 (et)
AT (1) ATE286385T1 (et)
AU (1) AU746129B2 (et)
BR (1) BR9913400A (et)
CA (1) CA2341397C (et)
CZ (1) CZ300830B6 (et)
DE (1) DE69923074T2 (et)
EE (1) EE200100134A (et)
ES (1) ES2234296T3 (et)
HU (1) HU227278B1 (et)
ID (1) ID29629A (et)
IL (2) IL141439A0 (et)
IS (1) IS5869A (et)
MY (1) MY124359A (et)
NO (1) NO20011085L (et)
NZ (2) NZ509943A (et)
PL (1) PL195603B1 (et)
PT (1) PT1109537E (et)
RU (2) RU2252751C2 (et)
SA (1) SA99200683B1 (et)
SE (1) SE9802973D0 (et)
SK (1) SK285507B6 (et)
TR (2) TR200502188T2 (et)
TW (1) TW561056B (et)
UA (1) UA75567C2 (et)
WO (1) WO2000013671A1 (et)
ZA (1) ZA200101762B (et)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9802973D0 (sv) * 1998-09-03 1998-09-03 Astra Ab Immediate release tablet
SE9904377D0 (sv) * 1999-12-01 1999-12-01 Astra Pharma Prod Pharmaceutical combinations
RU2333757C2 (ru) * 2000-06-22 2008-09-20 Новартис Аг Фармацевтические композиции
US6462021B1 (en) 2000-11-06 2002-10-08 Astrazeneca Ab Use of low molecular weight thrombin inhibitor
US7129233B2 (en) * 2000-12-01 2006-10-31 Astrazeneca Ab Mandelic acid derivatives and their use as thrombin inhibitors
AR035216A1 (es) * 2000-12-01 2004-05-05 Astrazeneca Ab Derivados de acido mandelico ,derivados farmaceuticamente aceptables, uso de estos derivados para la fabricacion de medicamentos, metodos de tratamiento ,procesos para la preparacion de estos derivados, y compuestos intermediarios
AR034517A1 (es) * 2001-06-21 2004-02-25 Astrazeneca Ab Formulacion farmaceutica
SE0103369D0 (sv) * 2001-10-09 2001-10-09 Astrazeneca Ab Pharmaceutical formulation
FR2833493B1 (fr) * 2001-12-18 2005-09-23 Ioltechnologie Production Forme galenique solide et soluble pour l'administration occulaire de principes actifs et procede de fabrication d'un insert ophtalmique solide et soluble
US20030181488A1 (en) 2002-03-07 2003-09-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Administration form for the oral application of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester and the salts thereof
PT1488790E (pt) * 2002-03-28 2014-10-10 Teijin Pharma Ltd Preparação sólida contendo uma forma de cristal único a de um derivado de ácido tiazolcarboxílico
SE0201659D0 (sv) * 2002-05-31 2002-05-31 Astrazeneca Ab Modified release pharmaceutical formulation
SE0201658D0 (sv) * 2002-05-31 2002-05-31 Astrazeneca Ab Immediate release pharmaceutical formulation
SE0201661D0 (sv) 2002-05-31 2002-05-31 Astrazeneca Ab New salts
EP2982668A3 (en) 2002-12-03 2016-04-13 Pharmacyclics LLC 2-(2-hydroxybiphenyl-3-yl)-1h-benzoimidazole-5-carboxamidine derivatives as factor viia inhibitors for the treatment of thromboembolic disorders
US7781424B2 (en) * 2003-05-27 2010-08-24 Astrazeneca Ab Modified release pharmaceutical formulation
CA2552114A1 (en) * 2003-12-31 2005-07-21 Actavis Group Hf Solid dosage formulations of galantamine
KR100574554B1 (ko) * 2004-05-28 2006-04-27 한미약품 주식회사 니아신의 경구투여용 서방성 조성물
US8022053B2 (en) * 2004-11-02 2011-09-20 Bayer Schering Pharma Aktiengesellschaft Oral solid dosage forms containing a low dose of estradiol
US7524354B2 (en) * 2005-07-07 2009-04-28 Research Foundation Of State University Of New York Controlled synthesis of highly monodispersed gold nanoparticles
CN101478979B (zh) * 2006-06-29 2012-07-25 株式会社津村 含中药提取物片剂组合物
TW200827336A (en) * 2006-12-06 2008-07-01 Astrazeneca Ab New crystalline forms
PT2118074E (pt) 2007-02-01 2014-03-20 Resverlogix Corp Compostos para a prevenção e tratamento de doenças cardiovasculares
US20090061000A1 (en) * 2007-08-31 2009-03-05 Astrazeneca Ab Pharmaceutical formulation use 030
DE102008014237A1 (de) * 2008-03-14 2009-09-17 J. Rettenmaier & Söhne Gmbh + Co. Kg Direktverpressbares Tablettierhilfsmittel
DK2407166T3 (da) * 2009-03-13 2013-10-07 Toyama Chemical Co Ltd Tablet og granuleret pulver indeholdende 6-fluor-3-hydroxy-2-pyrazin-carboxamid
NZ708314A (en) 2009-03-18 2017-08-25 Resverlogix Corp Quinazolinones for use as anticancer agents
BRPI1014956B8 (pt) 2009-04-22 2021-05-25 Resverlogix Corp agentes anti-inflamatórios
PL2773354T3 (pl) 2011-11-01 2019-12-31 Resverlogix Corp. Doustna formulacja o natychmiastowym uwalnianiu dla podstawowych chinazolinów
US10213421B2 (en) 2012-04-04 2019-02-26 Alkahest, Inc. Pharmaceutical formulations comprising CCR3 antagonists
WO2014080290A2 (en) 2012-11-21 2014-05-30 Rvx Therapeutics Inc. Cyclic amines as bromodomain inhibitors
US9765039B2 (en) 2012-11-21 2017-09-19 Zenith Epigenetics Ltd. Biaryl derivatives as bromodomain inhibitors
JP2016507496A (ja) 2012-12-21 2016-03-10 ゼニス・エピジェネティクス・コーポレイションＺｅｎｉｔｈ Ｅｐｉｇｅｎｅｔｉｃｓ Ｃｏｒｐ． ブロモドメイン阻害剤としての新規複素環式化合物
GB201400034D0 (en) * 2014-01-02 2014-02-19 Astrazeneca Ab Pharmaceutical Compositions comprising AZD9291
JO3789B1 (ar) 2015-03-13 2021-01-31 Resverlogix Corp التراكيب والوسائل العلاجية المعتمدة لمعالجة الامراض المتعلقة بالمتممة

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1601833A (en) 1978-02-06 1981-11-04 Wellcome Found Antacid formulation
US4517179A (en) * 1983-04-29 1985-05-14 Pennwalt Corporation Rapid dissolving, uniform drug compositions and their preparation
IT1200178B (it) 1986-07-23 1989-01-05 Alfa Farmaceutici Spa Formulazioni galeniche a cessione programmata contenenti farmaci ad attivita' antiflogistica
AR240018A1 (es) * 1987-10-07 1990-01-31 Merrell Pharma Inc Procedimiento para preparar una composicion que comprende derivados de piperidinoalcanol.
US5430023A (en) * 1990-09-28 1995-07-04 Eli Lilly And Company Tripeptide antithrombotic agents
SE9102462D0 (sv) 1991-08-28 1991-08-28 Astra Ab New isosteric peptides
SE9103612D0 (sv) * 1991-12-04 1991-12-04 Astra Ab New peptide derivatives
US5532267A (en) * 1992-02-10 1996-07-02 Torii & Co., Ltd. Amidinonaphthyl furancarboxylate derivatives and acid addition salts therof
US5470955A (en) 1993-02-02 1995-11-28 Dartmouth College Antibodies which specifically bind mcl-1 polypeptide
SE9301916D0 (sv) 1993-06-03 1993-06-03 Ab Astra New peptides derivatives
US5436229A (en) * 1994-03-04 1995-07-25 Eli Lilly And Company Bisulfite adducts of arginine aldehydes
CA2193681A1 (en) 1994-07-08 1996-01-25 Astra Aktiebolag New oral pharmaceutical formulation containing magnesium salt of omeprazole
US5510369A (en) * 1994-07-22 1996-04-23 Merck & Co., Inc. Pyrrolidine thrombin inhibitors
DE19530575A1 (de) * 1995-08-19 1997-02-20 Gruenenthal Gmbh Schnell zerfallende Arzneiform von Tramadol oder einem Tramadolsalz
US5733578A (en) 1995-11-15 1998-03-31 Edward Mendell Co., Inc. Directly compressible high load acetaminophen formulations
TW430561B (en) 1995-12-20 2001-04-21 Gea Farmaceutisk Fabrik As Rapid release tablet composition comprising tolfenamic acid or a pharmaceutically acceptable salt thereof as active ingredient and a method of preparing such tablet
TWI238827B (en) 1995-12-21 2005-09-01 Astrazeneca Ab Prodrugs of thrombin inhibitors
EP0803251B1 (en) * 1996-04-23 2002-07-17 Janssen Pharmaceutica N.V. Immediate release pH-independent solid dosage form of cisapride
SE9601556D0 (sv) * 1996-04-24 1996-04-24 Astra Ab New pharmaceutical formulation of a thrombin inhibitor for parenteral use
DE19628617A1 (de) * 1996-07-16 1998-01-22 Basf Ag Direkttablettierhilfsmittel
AU723315B2 (en) * 1996-09-18 2000-08-24 Merck & Co., Inc. Combination therapy for reducing the risks associated with cardiovascular disease
HRP970493A2 (en) * 1996-09-23 1998-08-31 Wienman E. Phlips Oral delayed immediate release medical formulation and method for preparing the same
SE9603724D0 (sv) * 1996-10-11 1996-10-11 Astra Ab New pharmaceutical parenteral formulation of a thrombin inhibitor
US5798377A (en) * 1996-10-21 1998-08-25 Merck & Co., Inc. Thrombin inhibitors
UA69413C2 (uk) 1998-05-22 2004-09-15 Брістол-Майерс Сквібб Компані Фармацевтична композиція, яка містить серцевину та ентеросолюбільну оболонку, фармацевтична композиція у вигляді сфероїдальних гранул, спосіб одержання сфероїдальних гранул та спосіб одержання фармацевтичної композиції
GB9814215D0 (en) 1998-07-01 1998-09-02 Norton Healthcare Ltd Anti-inflammatory pharmaceutical formulations
CA2239931A1 (en) 1998-07-15 2000-01-15 Bernard Charles Sherman Pharmaceutical tablet comprising norfloxacin
US6368625B1 (en) 1998-08-12 2002-04-09 Cima Labs Inc. Orally disintegrable tablet forming a viscous slurry
SE9802973D0 (sv) * 1998-09-03 1998-09-03 Astra Ab Immediate release tablet
US6602521B1 (en) 1998-09-29 2003-08-05 Impax Pharmaceuticals, Inc. Multiplex drug delivery system suitable for oral administration
US6217904B1 (en) 1999-04-06 2001-04-17 Pharmaquest Ltd. Pharmaceutical dosage form for pulsatile delivery of d-threo-methylphenidate and a second CNS stimulant
IE20000271A1 (en) 1999-04-13 2001-04-04 Beecham Pharm Pte Ltd Pharmaceutical Formulations of Amoxycillin and Potassium Clavulanate

Also Published As

Publication number Publication date
NZ539749A (en) 2006-11-30
UA75567C2 (en) 2006-05-15
CA2341397C (en) 2009-02-03
ATE286385T1 (de) 2005-01-15
ID29629A (id) 2001-09-06
HU227278B1 (en) 2011-01-28
DE69923074T2 (de) 2005-12-08
PL346545A1 (en) 2002-02-11
CN1158070C (zh) 2004-07-21
US20050208128A1 (en) 2005-09-22
US6875446B2 (en) 2005-04-05
SE9802973D0 (sv) 1998-09-03
TR200502188T2 (tr) 2006-12-21
CN1951371A (zh) 2007-04-25
HUP0103886A3 (en) 2002-08-28
IL141439A (en) 2006-07-05
SA99200683B1 (ar) 2006-12-05
NZ509943A (en) 2004-01-30
JP4026678B2 (ja) 2007-12-26
BR9913400A (pt) 2001-05-22
WO2000013671A1 (en) 2000-03-16
MY124359A (en) 2006-06-30
RU2252751C2 (ru) 2005-05-27
KR20010090436A (ko) 2001-10-18
NO20011085D0 (no) 2001-03-02
CA2341397A1 (en) 2000-03-16
HUP0103886A2 (hu) 2002-04-29
PT1109537E (pt) 2005-04-29
JP2002524412A (ja) 2002-08-06
KR100696350B1 (ko) 2007-03-20
SK2812001A3 (en) 2001-09-11
SK285507B6 (sk) 2007-03-01
CN1544088A (zh) 2004-11-10
EP1109537B1 (en) 2005-01-05
CZ2001774A3 (cs) 2001-10-17
JP2007039472A (ja) 2007-02-15
ES2234296T3 (es) 2005-06-16
US20030118644A1 (en) 2003-06-26
RU2005100986A (ru) 2006-06-20
KR20060097071A (ko) 2006-09-13
NO20011085L (no) 2001-05-03
EP1527787A1 (en) 2005-05-04
US6521253B1 (en) 2003-02-18
TW561056B (en) 2003-11-11
DE69923074D1 (de) 2005-02-10
IL141439A0 (en) 2002-03-10
AU5892499A (en) 2000-03-27
CZ300830B6 (cs) 2009-08-19
IS5869A (is) 2001-02-28
ZA200101762B (en) 2002-06-03
AU746129B2 (en) 2002-04-18
EP1109537A1 (en) 2001-06-27
CN1315855A (zh) 2001-10-03
AR029313A1 (es) 2003-06-25
PL195603B1 (pl) 2007-10-31
TR200100666T2 (tr) 2001-08-21

Similar Documents

Publication Publication Date Title
EE200100134A (et) Kiiresti vabastav tablett
DE60013812D1 (de) Schnellkupplung
DE60038784D1 (de) Schnellkupplung
NO20010919L (no) Forlenget frigjøring bukkal bioadhesiv tablett
DE59906289D1 (de) Notbefreiungseinrichtung
PT1058538E (pt) Comprimidos de desintegracao rapida
ID23735A (id) Tablet trovafloksasin mesilat
DE69816760D1 (de) Trennfolie
DE60034307D1 (de) Kombinierte kamera
DE69922630D1 (de) Trennfolie
DE50015811D1 (de) Retardersystem
NO993944L (no) Utlösermekanisme
DE60044181D1 (de) Gleitvorrichtung
DE69907022D1 (de) Tablettenspender
DE69915818D1 (de) Zuckerbeschichtete tabletten
DE50015381D1 (de) Retardersystem
DE69814051D1 (de) Trennmittel
DE69812401D1 (de) Schnellkupplung
PT879576E (pt) Retrete
FI981576A0 (fi) Irrokepaperi
DE69717810D1 (de) S1452-tabletten mit schneller freisetzung
ITPR980020A1 (it) Incorniciatura rapida
SE9802667D0 (sv) Snabbkoppling
SE9904410D0 (sv) Snabbkoppling
DE69620917D1 (de) Schnellkupplung